Graphic analysis of flow-volume curves: A pilot study

BMC Pulmonary Medicine

Volumn 16, Issue 1, 2016, Pages

  Lee, Jungsil ^a   Lee, Choon Taek ^a   Lee, Jae Ho ^a   Cho, Young Jae ^a   Park, Jong Sun ^a   Oh, Yeon Mok ^b   Lee, Sang Do ^b   Yoon, Ho Il ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Chronic obstructive; Maximal expiratory flow volume curves; Pulmonary disease; Spirometry

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FLOW VOLUME CURVE; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PILOT STUDY; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VALIDATION STUDY; WALKING; EXERCISE TOLERANCE; HEALTH STATUS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAL CAPACITY;

AGED; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MAXIMAL EXPIRATORY FLOW-VOLUME CURVES; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 84960094843     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-016-0182-8     Document Type: Article

References (21)

1. Jones PW. Health status and the spiral of decline. COPD. 2009;6(1):59-63. doi: 10.1080/15412550802587943.
2. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972-7. doi: 10.1164/rccm.200407-855OC.
3. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521-37. doi: 10.1183/09031936.00046814.
4. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997;52(1):67-71.
5. Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS, Koeter GH. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J. 1994;7(2):269-73.
6. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119(1):256-70.
7. Sovijarvi AR. Flow-volume response to inhaled methacholine in asthmatics; comparison of area under the curve (AFV) with conventional parameters. Eur J Respir Dis Suppl. 1986;143:18-21.
8. Seppala OP. Reproducibility of methacholine induced bronchoconstriction in healthy subjects: the use of area under the expiratory flow-volume curve to express results. Respir Med. 1990;84(5):387-94.
9. Lapp NL, Hyatt RE. Some factors affecting the relationship of maximal expiratory flow to lung volume in health and disease. Dis Chest. 1967;51(5):475-81.
10. Park TS, Lee JS, Seo JB, Hong Y, Yoo JW, Kang BJ, et al. Study design and outcomes of Korean Obstructive Lung Disease (KOLD) cohort study. Tuberculosis and Respiratory Diseases. 2014;76(4):169-74. doi: 10.4046/trd.2014.76.4.169.
11. Eom SY, Kim H. Reference values for the pulmonary function of Korean adults using the data of Korea National Health and Nutrition Examination Survey IV (2007-2009). J Korean Med Sci. 2013;28(3):424-30. doi: 10.3346/jkms.2013.28.3.424.
12. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology (Carlton, Vic). 2011;16(4):659-65. doi: 10.1111/j.1440-1843.2011.01951.x.
13. Mead J. Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol. 1978;44(2):156-65.
14. Kraan J, van der Mark TW, Koeter GH. Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids. Thorax. 1989;44(12):1015-21.
15. Kapp MC, Schachter EN, Beck GJ, Maunder LR, Witek Jr TJ. The shape of the maximum expiratory flow volume curve. Chest. 1988;94(4):799-806.
16. Schachter EN, Kapp MC, Maunder LR, Beck G, Witek TJ. Smoking and cotton dust effects in cotton textile workers: an analysis of the shape of the maximum expiratory flow volume curve. Environ Health Perspect. 1986;66:145-8.
17. Vermaak JC, Bunn AE, de Kock MA. A new lung function index: the area under the maximum expiratory flow-volume curve. Respiration. 1979;37(2):61-5.
18. Struthers AD, Addis GJ. Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patients. Eur J Clin Pharmacol. 1988;34(3):277-81.
19. Nozoe M, Mase K, Murakami S, Okada M, Ogino T, Matsushita K, et al. Relationship between spontaneous expiratory flow-volume curve pattern and air-flow obstruction in elderly COPD patients. Respir Care. 2013;58(10):1643-8. doi: 10.4187/respcare.02296.
20. Ma S, Hecht A, Varga J, Rambod M, Morford S, Goto S, et al. Breath-by-breath quantification of progressive airflow limitation during exercise in COPD: a new method. Respir Med. 2010;104(3):389-96. doi: 10.1016/j.rmed.2009.10.014.
21. Williams EM, Powell T, Eriksen M, Neill P, Colasanti R. A pilot study quantifying the shape of tidal breathing waveforms using centroids in health and COPD. J Clin Monit Comput. 2014;28(1):67-74. doi: 10.1007/s10877-013-9497-7.